Javier Munoz

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

J. Vose, L. Lekakis, M. Lunning, 2023, Blood advances.

Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20+ B-Cell Lymphoma.

J. Westin, V. Bachanova, R. Nath, 2023, Transplantation and cellular therapy.